{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:38:32Z","timestamp":1776465512244,"version":"3.51.2"},"reference-count":26,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institut Pasteur","award":["ANR AB 2022 DARRI INNOV-204-24 TAHA"],"award-info":[{"award-number":["ANR AB 2022 DARRI INNOV-204-24 TAHA"]}]},{"name":"Institut Pasteur","award":["S-CR23002-08A"],"award-info":[{"award-number":["S-CR23002-08A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background:\u00a0Haemophilus influenzae (Hi), a Gram-negative bacterium, is divided into two broad categories: encapsulated and non-capsulated isolates, also called non-typeable Hi isolates (NTHi). NTHi has become prevalent since the introduction of the vaccine against Hi of serotype b. Hi can cause local infections on respiratory mucosal surfaces and urogenital infections, which can lead to septic abortion in pregnant women. It can also cause invasive infections such as meningitis and septicemia. Moreover, NTHi isolates are becoming increasingly resistant to antibiotics. Vaccines targeting NTHi are not yet available. As these NTHi isolates are not encapsulated, vaccines should target proteins at the bacterial surface. However, vaccine development is hindered by the high variability of these proteins. We aimed to identify conserved outer membrane proteins (OMPs) for vaccines against NTHi. Methods: We analyzed core-genome multilocus sequence typing (cgMLST) of 1144 genomes of Hi collected between 2017 and 2022 and, of these, identified 514 conserved genes that encoded OMPs. We focused on two specific OMPs: Haem1295, encoding the protein P5 (P5), and Haem1040, encoding the protein 26 (P26). P5 is known to bind human complement regulatory protein factor H (FH), while both P5 and P26 are involved in enhancing immune responses. The genes encoding these proteins were cloned, overexpressed, purified, and tested in both active and passive protection models using systemic infection in mice. Results: P5 and P26 were found to be immunogenic during human infections. Vaccination with these proteins conferred protection against both homologous and heterologous NTHi isolates in mice, suggesting broad cross-protection. Conclusions: P5 and P26 are promising vaccine candidates showing cross-protection against NTHi and offering the additional benefit of targeting bacterial virulence factors, enhancing vaccine efficacy against NTHi isolates.<\/jats:p>","DOI":"10.3390\/vaccines13090892","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:57:47Z","timestamp":1755878267000},"page":"892","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-Component Vaccine Candidates Against Non-Typeable Haemophilus influenzae"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-8306","authenticated-orcid":false,"given":"Nouria","family":"Belkacem","sequence":"first","affiliation":[{"name":"Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and <i>Haemophilus influenzae<\/i>, 75724 Paris Cedex 15, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-1732","authenticated-orcid":false,"given":"Ala-Eddine","family":"Deghmane","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and <i>Haemophilus influenzae<\/i>, 75724 Paris Cedex 15, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and <i>Haemophilus influenzae<\/i>, 75724 Paris Cedex 15, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref_1","first-page":"185","article-title":"Biotypes, serotypes, and susceptibility to antibiotics of 60 Haemophilus influenzae strains from genitourinary tracts","volume":"64","author":"Casin","year":"1988","journal-title":"Genitourin. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.inf.0000148233.57296.90","article-title":"Haemophilus influenzae: A significant pathogen in acute otitis media","volume":"23","author":"Leibovitz","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00006454-198906000-00002","article-title":"Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine","volume":"8","author":"Takala","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/adc.2007.126888","article-title":"Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign","volume":"93","author":"Ladhani","year":"2008","journal-title":"Arch. Dis. Child."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1155\/S1064744902000170","article-title":"Haemophilus influenzae septic abortion","volume":"10","author":"Cherpes","year":"2002","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1002\/1873-3468.12351","article-title":"Host-pathogen interactions of nontypeable Haemophilus influenzae: From commensal to pathogen","volume":"590","author":"Duell","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/infdis\/jiad584","article-title":"Biofilm Formation by Nontypeable Haemophilus influenzae and Resistance to Complement-Mediated Clearance","volume":"229","author":"Belkacem","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_8","first-page":"CD010010","article-title":"Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease","volume":"6","author":"Teo","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1080\/21645515.2016.1174354","article-title":"Why we need a vaccine for non-typeable Haemophilus influenzae","volume":"9","author":"Cerquetti","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jinf.2019.05.007","article-title":"High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to third generation cephalosporins by alteration of ftsI gene","volume":"79","author":"Deghmane","year":"2019","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/molbev\/msj030","article-title":"Application of phylogenetic networks in evolutionary studies","volume":"23","author":"Huson","year":"2006","journal-title":"Mol. Biol. Evol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-2836(86)90385-2","article-title":"Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes","volume":"189","author":"Studier","year":"1986","journal-title":"J. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1128\/AAC.00378-16","article-title":"Use of Animal Models to Support Revising Meningococcal Breakpoints of beta-Lactams","volume":"60","author":"Belkacem","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/IAI.67.4.1935-1942.1999","article-title":"Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein","volume":"67","author":"Kyd","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Weeks, J.R., Staples, K.J., Spalluto, C.M., Watson, A., and Wilkinson, T.M.A. (2021). The Role of Non-Typeable Haemophilus influenzae Biofilms in Chronic Obstructive Pulmonary Disease. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.720742"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.2147\/IDR.S424468","article-title":"Epidemic Trends and Biofilm Formation Mechanisms of Haemophilus influenzae: Insights into Clinical Implications and Prevention Strategies","volume":"16","author":"Xiao","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1128\/IAI.71.8.4691-4699.2003","article-title":"Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx","volume":"71","author":"Kyd","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/S0264-410X(00)00288-7","article-title":"Developing a nontypeable Haemophilus influenzae (NTHi) vaccine","volume":"19","author":"Poolman","year":"2000","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/S0264-410X(02)00306-7","article-title":"Detection and characterization of pediatric serum antibody to the OMP P5-homologous adhesin of nontypeable Haemophilus influenzae during acute otitis media","volume":"20","author":"Novotny","year":"2002","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2012.08.019","article-title":"The Kompa family of proteins: Roles in bacterial pathogenesis and immunity","volume":"163","author":"Confer","year":"2013","journal-title":"Vet. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/mmi.12741","article-title":"Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance","volume":"94","author":"Langereis","year":"2014","journal-title":"Mol. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4161\/hv.7.0.14569","article-title":"Effectiveness of engineering the nontypeable Haemophilus influenzae antigen Omp26 as an S-layer fusion in bacterial ghosts as a mucosal vaccine delivery","volume":"7","author":"Riedmann","year":"2011","journal-title":"Hum. Vaccines"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/2211-5463.13498","article-title":"Haemophilus influenzae Protein D antibody suppression in a multi-component vaccine formulation","volume":"12","author":"Michel","year":"2022","journal-title":"FEBS Open Bio"},{"key":"ref_25","unstructured":"ECDC (2025). Annual Epidemiological Report for 2023\u2014Haemophilus influenzae Disease, European Centre for Disease Prevention and Control."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0038-1660818","article-title":"Biofilm biology and vaccine strategies for otitis media due to nontypeable Haemophilus influenzae","volume":"14","author":"Novotny","year":"2019","journal-title":"J. Pediatr. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/892\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:20Z","timestamp":1760034860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/9\/892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["vaccines13090892"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13090892","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}